In solid tumors such as lung, melanoma, and esophageal cancer, high infiltration of FoxP3+ Tregs in tumor tissues was detected, and an increased immune response was observed after selective depletion of FoxP3+ Tregs using different immunotherapies [23–25]. The gene discussed is FOXP3; the disease is melanoma.